Differences in potential for selection of clindamycin-resistant mutants between inducible erm(A) and erm(C) Staphylococcus aureus genes

Journal of Clinical Microbiology

Volumn 46, Issue 2, 2008, Pages 546-550

  Daurel, Claire ^a,b   Huet, Corinne ^b,d   Dhalluin, Anne ^b,c   Bes, Michèle ^e   Etienne, Jerome ^e   Leclercq, Roland ^a,b,f  

^a CHU CÔTE DE NACRE   (France)

^b UNIVERSITÉ DE CAEN   (France)

^c UNIVERSITÉ DE CAEN   (France)

^d Louis Pasteur Hospital   (France)

^e UNIVERSITÉ LYON 1   (France)

^f CAEN UNIVERSITY HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CLINDAMYCIN; ERYTHROMYCIN; LINCOSAMIDE; MACROLIDE; MIKAMYCIN B; OLEANDOMYCIN;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL GENE; BACTERIUM ISOLATE; BACTERIUM MUTANT; CONTROLLED STUDY; DISK DIFFUSION; ERM A GENE; ERM C GENE; MOLECULAR CLONING; MSR A GENE; MUTATION RATE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; STAPHYLOCOCCUS; STAPHYLOCOCCUS AUREUS;

ANTI-BACTERIAL AGENTS; BACTERIAL PROTEINS; CLINDAMYCIN; DNA, BACTERIAL; DRUG RESISTANCE, BACTERIAL; MACROLIDES; METHYLTRANSFERASES; MUTATION; SELECTION (GENETICS); SEQUENCE ANALYSIS, DNA; STAPHYLOCOCCUS AUREUS; STREPTOGRAMIN GROUP B;

STAPHYLOCOCCUS; STAPHYLOCOCCUS AUREUS;

EID: 38949131177     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/JCM.01925-07     Document Type: Article

References (19)

1. Comité de l'Antibiogramme de la Société Française de Microbiologie. 2007. Communiqué 2007. Société Française de Microbiologie, Paris, France. http://www.sfm.asso.fr/.
2. Depardieu, F., I. Podglajen, R. Leclercq, E. Collatz, and P. Courvalin. 2007. Modes and modulations of antibiotic resistance gene expression. Clin. Microbiol. Rev. 20:79-114.
3. Di Modugno, V., M. Guerrini, S. Shah, and J. Hamilton-Miller. 2002. Low level resistance to oleandomycin as a marker of ermA in staphylococci. J. Antimicrob. Chemother. 49:425-127.
4. Drinkovic, D., E. R. Fuller, K. P. Shore, D. J. Holland, and R. Ellis-Pegler. 2001. Clindamycin treatment of Staphylococcus aureus expressing inducible clindamycin resistance. J. Antimicrob. Chemother. 48:315-316.
5. Fleiss, J. L. 1981. Statistical methods for rates and populations, 2nd ed. Wiley, New York, NY.
6. Frank, A. L., J. F. Marcinak, P. D. Mangat, J. T. Tjhio, S. Kelkar, P. C. Schreckenberger, and J. P. Quinn. 2002. Clindamycin treatment of methicillin-resistant Staphylococcus aureus infections in children. Pediatr. Infect. Dis. J. 21:530-534.
7. Herbert, S., P. Barry, and R. P. Novick. 2001. Subinhibitory clindamycin differentially inhibits transcription of exoprotein genes in Staphylococcus aureus. Infect. Immun. 69:2996-3003.
8. Horinouchi, S., and B. Weisblum. 1982. Nucleotide sequence and functional map of pE194, a plasmid that specifies inducible resistance to macrolide, lincosamide, and streptogramin type B antibodies. J. Bacteriol. 150:804-814.
9. Leclercq, R. 2002. Mechanisms of resistance to macrolides and lincosamides: nature of the resistance elements and their clinical implications. Clin. Infect. Dis. 34:482-192.
10. Lewis, J. S., II, and J. H. Jorgensen. 2005. Inducible clindamycin resistance in staphylococci: should clinicians and microbiologists be concerned? Clin. Infect. Dis. 40:280-285.
11. Lina, G., A. Quaglia, M. E. Reverdy, R. Leclercq, F. Vandenesch, and J. Etienne. 1999. Distribution of genes encoding resistance to macrolides, lincosamides, and streptogramins among staphylococci. Antimicrob. Agents Chemother. 43:1062-1066.
12. Marcinak, J. F., and A. L. Frank. 2006. Epidemiology and treatment of community-associated methicillin-resistant Staphylococcus aureus in children. Expert Rev. Anti-Infect. Ther. 4:91-100.
13. Murphy, E. 1985. Nucleotide sequence of ermA, a macrolide-lincosamide-streptogramin B determinant in Staphylococcus aureus. J. Bacteriol. 162:633-640.
14. NCCLS/CLSI. 2004. Performance standards for antimicrobial susceptibility testing: 12th informational supplement. NCCLS document M100-S14. NCCLS/CLSI, Wayne, PA.
15. Prunier, A. L., B. Malbruny, M. Laurans, J. Brouard, J. F. Duhamel, and R. Leclercq. 2003. High rate of macrolide resistance in Staphylococcus aureus strains from patients with cystic fibrosis reveals high proportions of hypermutable strains. J. Infect. Dis. 187:1709-1716.
16. Rao, G. G. 2000. Should clindamycin be used in treatment of patients with infections caused by erythromycin-resistant staphylococci? J. Antimicrob. Chemother. 45:715.
17. Siberry, G. K., T. Tekle, K. Carroll, and J. Dick. 2003. Failure of clindamycin treatment of methicillin-resistant Staphylococcus aureus expressing inducible clindamycin resistance in vitro. Clin. Infect. Dis. 37:1257-1260.
18. Trieu-Cuot, P., C. Carlier, C. Poyart-Salmeron, and P. Courvalin. 1990. A pair of mobilizable shuttle vectors conferring resistance to spectinomycin for molecular cloning in Escherichia coli and in gram-positive bacteria. Nucleic Acids Res. 18:4296.
19. Tristan, A., M. Bes, H. Meugnier, G. Lina, B. Bozdogan, P. Courvalin, M. E. Reverdy, M. C. Enright, F. Vandenesch, and J. Etienne. 2007. Global distribution of Panton-Valentine leukocidin-positive methicillin-resistant Staphylococcus aureus, 2006. Emerg. Infect. Dis. 13:594-600.